HOME › DRUGS › ROZANOLIXIZUMAB
ACTIVE SUBSTANCE / INN

ROZANOLIXIZUMAB

Brand name(s): Rystiggo
EMA LISTED
AUTHORISED
Myasthenia Gravis
ACTIVE SUBSTANCE
Rozanolixizumab
REGULATORS
EMA
SPONSORS / MAH
UCB Pharma
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RystiggoUCB PharmaAuthorised05/01/2024Myasthenia Gravis

FULL INTELLIGENCE ON ROZANOLIXIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →